Survival impact of rituximab combined with ACVBP and upfront consolidation autotransplantation in high-risk diffuse large B-cell lymphoma for GELA

BACKGROUND: As rituximab combined with CHOP improves complete remission and overall survival in diffuse large B-cell lymphoma, intensified chemotherapy followed by autologous stem-cell transplantation has also been advocated for high-risk patients. The aim of this study was to establish whether or n...

詳細記述

保存先:
書誌詳細
主要な著者: Fitoussi, Olivier, Belhadj, Karim, Mounier, Nicolas, Parrens, Marie, Tilly, Hervé, Salles, Gilles, Feugier, Pierre, Ferme, Christophe, Ysebaert, Loic, Gabarre, Jean, Herbrecht, Raoul, Janvier, Maud, Van Den Neste, Eric, Morschhauser, Franck, Casasnovas, Olivier, Ghesquieres, Hervé, Anglaret, Bruno, Brechignac, Sabine, Haioun, Corinne, Gisselbrecht, Christian
フォーマット: Artigo
言語:Inglês
出版事項: Ferrata Storti Foundation 2011
主題:
Original Articles
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3148907/
https://ncbi.nlm.nih.gov/pubmed/21546499
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2010.038109
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料